Emergence of resistant Klebsiella pneumoniae in the intestinal tract during successful treatment of Klebsiella pneumoniae lung infection in rats

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 7, 2010, Pages 2960-2964

  Kesteman, Anne Sylvie ^a,b   Perrin Guyomard, Agnès ^b   Laurentie, Michel ^b   Sanders, Pascal ^b   Toutain, Pierre Louis ^a   Bousquet Mélou, Alain ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b Healthy Pigs Production and Experimentation Section   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MARBOFLOXACIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; DRUG EFFECT; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FECES ANALYSIS; GASTROINTESTINAL INFECTION; INTESTINE FLORA; KLEBSIELLA PNEUMONIAE; LUNG INFECTION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG EFFECTS; INTESTINE; LUNG DISEASES; MALE; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FLUOROQUINOLONES; INTESTINES; KLEBSIELLA PNEUMONIAE; LUNG DISEASES; MALE; RATS;

EID: 77953736189     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01612-09     Document Type: Article

References (24)

1. Bakker-Woudenberg, I. A., J. Y. de Jong-Hoenderop, and M. F. Michel. 1979. Efficacy of antimicrobial therapy in experimental rat pneumonia: effects of impaired phagocytosis. Infect. Immun. 25:366-375.
2. Bourgeois-Nicolaos, N., L. Massias, B. Couson, M. J. Butel, A. Andremont, and F. Doucet-Populaire. 2007. Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo. J. Infect. Dis. 195:1480-1488.
3. CLSI. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. Seventh edition. Document M7-A7. CLSI, Wayne, PA.
4. Donskey, C. J. 2004. The role of the intestinal tract as a reservoir and source for transmission of nosocomial pathogens. Clin. Infect. Dis. 39:219-226.
5. Ferran, A. A., A. S. Kesteman, P. L. Toutain, and A. Bousquet-Melou. 2009. Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection model. Antimicrob. Agents Chemother. 53:3384-3390.
6. Hasegawa, T., K. Takagi, and K. Kitaichi. 1999. Effects of bacterial endotoxin on drug pharmacokinetics. Nagoya J. Med. Sci. 62:11-28.
7. Hoyen, C. K., N. J. Pultz, D. L. Paterson, D. C. Aron, and C. J. Donskey. 2003. Effect of parenteral antibiotic administration on establishment of intestinal colonization in mice by Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 47:3610-3612.
8. Ismail, M., and Y. A. El-Kattan. 2007. Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves. Res. Vet. Sci. 82:398-404.
9. Kesteman, A. S., A. A. Ferran, A. Perrin-Guyomard, M. Laurentie, P. Sanders, P. L. Toutain, and A. Bousquet-Melou. 2009. Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model. Antimicrob. Agents Chemother. 53:4740-4748.
10. Martins, I. S., C. L. Pessoa-Silva, S. A. Nouer, E. G. Pessoa de Araujo, A. L. Ferreira, L. W. Riley, and B. M. Moreira. 2006. Endemic extended-spectrum beta-lactamase-producing Klebsiella pneumoniae at an intensive care unit: risk factors for colonization and infection. Microb. Drug Resist. 12:50-58.
11. Montgomerie, J. Z. 1979. Epidemiology of Klebsiella and hospital-associated infections. Rev. Infect. Dis. 1:736-753.
12. Neuhauser, M. M., R. A. Weinstein, R. Rydman, L. H. Danziger, G. Karam, and J. P. Quinn. 2003. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 289:885-888.
13. Pellet, T., M. Gicquel-Bruneau, P. Sanders, and M. Laurentie. 2006. Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli. Res. Vet. Sci. 80:324-335.
14. Peyrou, M., M. Y. Doucet, A. Vrins, D. Concordet, M. Schneider, and A. Bousquet-Melou. 2004. Population pharmacokinetics of marbofloxacin in horses: preliminary analysis. J. Vet. Pharmacol. Ther. 27:283-288.
15. Pultz, M. J., M. M. Nerandzic, U. Stiefel, and C. J. Donskey. 2008. Emergence and acquisition of fluoroquinolone-resistant gram-negative bacilli in the intestinal tracts of mice treated with fluoroquinolone antimicrobial agents. Antimicrob. Agents Chemother. 52:3457-3460.
16. Pultz, N. J., U. Stiefel, and C. J. Donskey. 2005. Effects of daptomycin, linezolid, and vancomycin on establishment of intestinal colonization with vancomycin-resistant enterococci and extended-spectrum-beta-lactamaseproducing Klebsiella pneumoniae in mice. Antimicrob. Agents Chemother. 49:3513-3516.
17. Richard, P., M. H. Delangle, F. Raffi, E. Espaze, and H. Richet. 2001. Impact of fluoroquinolone administration on the emergence of fluoroquinoloneresistant gram-negative bacilli from gastrointestinal flora. Clin. Infect. Dis. 32:162-166.
18. Safdar, N., and D. G. Maki. 2002. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann. Intern. Med. 136:834-844.
19. Schneider, M., V. Thomas, B. Boisrame, and J. Deleforge. 1996. Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration. J. Vet. Pharmacol. Ther. 19:56-61.
20. Spencer, R. C. 1996. Predominant pathogens found in the European Prevalence of Infection in Intensive Care Study. Eur. J. Clin. Microbiol. Infect. Dis. 15:281-285.
21. Stecher, B., and W. D. Hardt. 2008. The role of microbiota in infectious disease. Trends Microbiol. 16:107-114.
22. Sullivan, A., C. Edlund, and C. E. Nord. 2001. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 1:101-114.
23. Wiener, J., J. P. Quinn, P. A. Bradford, R. V. Goering, C. Nathan, K. Bush, and R. A. Weinstein. 1999. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517-523.
24. Yagci, D., F. Yoruk, A. Azap, and O. Memikoglu. 2009. Prevalence and risk factors for selection of quinolone-resistant Escherichia coli strains in fecal flora of patients receiving quinolone therapy. Antimicrob. Agents Chemother. 53:1287-1289.